Mindful Self-Compassion for Lung Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how a mindfulness-based program can assist people with lung cancer who feel stigmatized. The program, Mindful Self-Compassion for Lung Cancer (MSC-LC), teaches mindfulness and self-compassion skills over 10 weeks. Researchers aim to determine if this program reduces stigma and enhances self-compassion compared to a waitlist group. Adults diagnosed with lung cancer who experience stigma and haven't recently completed a similar program or changed medications might be suitable for this trial. Participants will either join the program or receive mental health resources and participate later.
As an unphased trial, this study provides a unique opportunity to explore new methods for improving emotional well-being in those stigmatized by lung cancer.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but if you are on antidepressant, anxiolytic, antipsychotic, or mood stabilizing medications, your dose should not have been changed in the 8 weeks before joining the study.
What prior data suggests that this mindfulness-based intervention is safe for adults with lung cancer?
Research has shown that mindful self-compassion (MSC) is safe and well-tolerated by patients. Studies have found that MSC helps people be kinder to themselves and reduces feelings of shame and distress. Participants in these studies did not report any serious side effects or harm. Instead, they experienced small-to-medium improvements in symptoms of depression, stress, and loneliness.
The Mindful Self-Compassion for Lung Cancer (MSC-LC) program tailors these techniques specifically for people with lung cancer. It focuses on helping them develop mindfulness and self-compassion skills. The goal is to reduce the stigma and stress often associated with a lung cancer diagnosis. This approach is gentle and supportive, making it a safe choice for many.12345Why are researchers excited about this trial?
Researchers are excited about Mindful Self-Compassion for Lung Cancer (MSC-LC) because it offers a fresh approach to addressing the emotional and psychological challenges faced by patients. Unlike traditional treatments that focus on the physical aspects of lung cancer, MSC-LC is a group-based intervention that enhances mindfulness and self-compassion, aiming to reduce the stigma associated with the condition. This innovative method could provide an important complementary strategy alongside standard medical care, potentially improving the overall well-being and quality of life for patients.
What evidence suggests that Mindful Self-Compassion for Lung Cancer is effective in reducing stigma?
Research has shown that Mindful Self-Compassion (MSC) effectively increases self-kindness and reduces feelings of shame and distress in people with lung cancer. Early studies found that MSC helps individuals feel better about themselves and manage tough emotions. In this trial, participants in the Mindful Self-Compassion for Lung Cancer (MSC-LC) arm will engage in a program specifically designed to reduce stigma, the negative feeling associated with having lung cancer. By teaching mindfulness and self-compassion skills, this program aids in managing emotions and improving emotional well-being. Initial feedback from participants in similar programs indicates they feel less stigmatized and more compassionate toward themselves.12346
Who Is on the Research Team?
Timothy J Williamson, Ph.D., MPH
Principal Investigator
Loyola Marymount University
Are You a Good Fit for This Trial?
This trial is for adults with lung cancer who feel stigmatized because of their diagnosis. Participants will be randomly assigned to either learn mindfulness and self-compassion skills in a virtual group setting over 10 weeks or placed on a waitlist while receiving standard mental health resources.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the Mindful Self-Compassion for Lung Cancer (MSC-LC) intervention, a 10-week, virtually-delivered, group-based psychosocial intervention focused on mindfulness and self-compassion skills
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Mindful Self-Compassion for Lung Cancer (MSC-LC)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Loyola Marymount University
Lead Sponsor
National Cancer Institute (NCI)
Collaborator